CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Core Laboratories Inc. /DE/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$10.15+0.15 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $475.81M
- P/E (TTM)
- 19.5
- Dividend yield
- 0.39%
Share price
−$1.19 (−10.49%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Core Laboratories Inc. /DE/ grew revenue 0.3% to $519.18M over the twelve months to Jun 30, 2026. Operating income fell 11.0% to $47.80M, moving the operating margin from 10.4% to 9.2%. Free cash flow was $15.14M, down 64.0% from a year earlier.
Revenue
$519.18M
+0.3% vs. a year earlier
Operating income
$47.80M
-11.0% vs. a year earlier
Free cash flow
$15.14M
-64.0% vs. a year earlier
EPS, diluted
$0.52
-17.5% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $475.81M
- P/E ratio
- 19.5
- Price to sales
- 0.92
- Price to book
- 1.75
- Dividend yield
- 0.39%
- Free cash flow yield
- 3.18%
Fundamentals
- Revenue
- $519.18M
- Net income
- $24.35M
- EPS, diluted
- $0.52
- Free cash flow
- $15.14M
- Book value per share
- $5.82
- Diluted shares
- 47M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$519.18M+0.3% YoY
Gross profit
$101.32M+0.1% YoY
Operating income
$47.80M-11.0% YoY
Net income
$24.35M-17.8% YoY
EPS, diluted
$0.52-17.5% YoY
Free cash flow
$15.14M-64.0% YoY
Reported periodTrailing twelve months